Published pharmacokinetic data on BPC-157 in humans do not exist in the peer-reviewed clinical literature
Aging Pathobiology and Therapeutics (2022) 4
So a tiny little needle, and it needs to be near the site of injection, not right on the site of injection, because that where the, I mean, site of injury, not injection
BPC-157 is classified as a research compound, not a dietary supplement
For gastrointestinal indications, systemic or oral administration is appropriate because the entire gut is the target
When considering AOD 9604 vs Tirzepatide, healthcare providers often weigh several factors: AOD 9604 may suit those seeking a fat loss boost without major systemic effects or appetite suppression